person
as of 2026-07-01Global Clinical Director Solvay
at a glance
Roles: Study Director
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Solvay Pharmaceuticals
Roles
Study Director
Trial investigator
no
Trials led
9
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
NCT00396214Phase 3Terminated
To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox
NCT00141479Phase 2Completed
Patient-reported Outcomes in the Treatment of Schizophrenia
NCT00230828Phase 3Completed
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
NCT00347425Phase 3Completed
Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia
NCT00139906Phase 2Completed
Bifeprunox in the Treatment of Schizophrenia
NCT00193687Phase 3Completed
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder
NCT00139919Phase 2Completed
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
NCT00160147Phase 3Terminated
Bifeprunox in the Treatment of Schizophrenia
NCT00193713Phase 3Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR
trial